文献速递神经肿瘤

生长激素分泌型垂体腺瘤合并高催乳素血症的临床特征与病理特征

Clinical characteristics and pathological features of growth hormone-secreting pituitary adenoma combined with hyperprolactinemia.
PubMed 文献 · J Neurooncol · 2025-04-23

回顾性收集810例生长激素分泌型垂体腺瘤(GHPA)患者临床资料,比较高催乳素血症(HPRL)组与非HPRL组的临床病理特征,并按2022年垂体神经内分泌肿瘤(PitNET)分类比较各亚型差异。HPRL组视功能损害、溢乳更多,GH水平更高,肿瘤体积更大、海绵窦侵袭和视交叉压迫更重,乳腺生长激素细胞型PitNET比例更高;HPRL不影响生化缓解率;稀疏颗粒型生长激素细胞型PitNET最常见(46.19%),未成熟PIT-1谱系PitNET生化缓解率最低、肿瘤残留/复发率最高。

要点

  • HPRL组较非HPRL组视功能损害和溢乳更多、GH水平更高,肿瘤体积更大、海绵窦侵袭和视交叉压迫更重。
  • GHPA最常见病理类型为稀疏颗粒型生长激素细胞型PitNET(46.19%),其次为乳腺生长激素细胞型(17.37%)和多激素型(17.80%)。
  • 未成熟PIT-1谱系PitNET生化缓解率最低、肿瘤残留/复发率最高;HPRL不影响生化缓解率。

核心结论

  • 溢乳和视功能损害症状有助于GHPA合并HPRL患者的早期诊断。
  • HPRL虽伴肿瘤体积更大和侵袭性更强,但未显著影响生化缓解率。
  • 近半数GHPA为稀疏颗粒型生长激素细胞型PitNET,常与不良肿瘤结局相关,提示病理类型对预测临床预后有重要作用。

研究设计与样本

  • 回顾性收集810例诊断为GHPA患者的临床资料。
  • 按是否合并HPRL分为HPRL组与非HPRL组进行比较。
  • 按2022年PitNET病理分类对患者分型并比较各型差异。

主要发现

  • 与非HPRL组相比,HPRL组视力和/或视野损害及溢乳更多,GH水平更高。
  • HPRL组肿瘤体积显著更大,海绵窦侵袭和视交叉压迫更严重,乳腺生长激素细胞型PitNET比例更高。
  • GHPA最常见病理类型为稀疏颗粒型生长激素细胞型PitNET(46.19%)、乳腺生长激素细胞型PitNET(17.37%)和多激素型PitNET(17.80%)。
  • 未成熟PIT-1谱系PitNET患者生化缓解率最低、肿瘤残留/复发率最高。

关键数值与推荐

  • 稀疏颗粒型生长激素细胞型PitNET占46.19%。
  • 乳腺生长激素细胞型PitNET占17.37%。
  • 多激素型PitNET占17.80%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Large-scale reports on growth hormone-secreting pituitary adenomas (GHPA) with hyperprolactinemia (HPRL) remain limited. The relationship between clinical characteristics and pathological subtypes of GHPA patients, based on the 2022 classification of pituitary neuroendocrine tumors (PitNET), has rarely been elucidated. This study aims to enhance the understanding of clinicopathological features in GHPA and clarify differences between patients with and without HPRL. METHODS: We retrospectively collected the clinical data of 810 patients diagnosed with GHPA. The clinical and pathological characteristics were compared between the HPRL and non-HPRL groups. Patients were categorized according to 2022 pathological classification and their differences were compared. RESULTS: Compared to the non-HPRL group, the HPRL group exhibited more visual acuity/field impairment and galactorrhea and had higher GH levels. The tumor volume (TV) in the HPRL group was significantly larger, with more severe cavernous sinus invasion and optic chiasm compression, and a higher proportion of mammosomatotroph PitNETs. The most common pathological types of GHPA included sparsely granulated somatotroph PitNETs (46.19%), mammosomatotroph PitNETs (17.37%), and plurihormonal PitNETs (17.80%). Patients with immature PIT-1 lineage PitNETs had the lowest biochemical remission rate and highest tumor residual/recurrence rate. CONCLUSION: The symptoms of galactorrhea and visual acuity/field impairment contribute to early diagnosis in GHPA patients with HPRL. Although TV is larger and invasiveness is greater, HPRL does not significantly affect the biochemical remission rate. Nearly half of GHPA cases are sparsely granulated somatotroph PitNETs, which are often associated with poor tumor outcomes, highlighting the critical role of pathological type in predicting clinical prognosis.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Mo C, Liu X, Guo Y, et al. Clinical characteristics and pathological features of growth hormone-secreting pituitary adenoma combined with hyperprolactinemia. J Neurooncol. 2025. PMID: 40266500. doi:10.1007/s11060-025-05041-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。